Neuropathy Target Esterase: Rates of Turnover In Vivo Following Covalent Inhibition with Phenyl Di-n-Pentylphosphinate
Authors:
- 1 October 1988
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 51 (4) , 1097-1101
Abstract
Phenyl di-n-pentylphosphinate is a reasonably stable easily synthesized inhibitor of neuropathy target esterase (NTE) with low anticholinesterase activity. Like phenyl-methylsulphonyl fluoride it protects hens against neuropathic effects of compounds such as diisopropylphosphorofluoridate. At intervals up to 15 days after dosing hens (10 mg/kg s.c. to inhibit 90% NTE) assays were made of catalytically active and of phosphinylated NTE in autopsy tissue. The sum of these components was always within the range of catalytic activity in undosed controls. However, the half-life of reappearance of active NTE was 2.07 days ±0.13 (SD, n = 6) for brain and 3.62 days ± 0.23 (SD, n = 6) for spinal cord-shorter than after dosing with phenylmethylsulphonyl fluoride. It is proposed that: (1) The physiological turnover mechanism cannot distinguish between catalytically active and di-n-pentylphosphinylated NTE although initiation of organophosphate-induced delayed polyneuropathy might involve recognition of aged di-alkyl-phosphorylated NTE as “foreign”. (2) The short half-lives indicate a slow spontaneous dephosphinylation of inhibited NTE occurs in vivo as well as de novo synthesis. The difference in half-lives for brain and spinal cord NTE may be due to different rates of synthesis de novo or (more likely) to different rates of spontaneous reactivation of the inhibited NTE in the two tissues.Keywords
This publication has 11 references indexed in Scilit:
- Phenyl di-n-pentylphosphinate: a convenient reactivatible inhibitor for studies on neuropathy target esterase (NTE) and protection against organophosphate-induced delayed polyneuropathyToxicology Letters, 1988
- The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: Neuropathic and prophylactic effects of stereoisomeric esters of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivoToxicology and Applied Pharmacology, 1987
- Receptor or enzyme: The puzzle of NTE and organophosphate-induced delayed polyneuropathyTrends in Pharmacological Sciences, 1987
- The correlation between the recovery rate of neurotoxic esterase activity and sensitivity to organophosphorus-induced delayed neurotoxicityToxicology and Applied Pharmacology, 1984
- Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. A comparison of the aging behaviour of di-isopropyl phosphorofluoridate-labelled proteins in brain, spinal cord, liver, kidney and spleen from hen and in human placentaBiochemical Journal, 1983
- Neurotoxic esterase in peripheral nerve: Assay, inhibition, and rate of resynthesisToxicology and Applied Pharmacology, 1982
- Reactivation and aging of neurotoxic esterase inhibited by a variety of organophosphorus estersBiochemical Journal, 1980
- Rapid aging of neurotoxic esterase after inhibition by di-isopropyl phosphorofluoridateBiochemical Journal, 1979
- Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potentialArchives of Toxicology, 1977
- THE PRIMARY BIOCHEMICAL LESION LEADING TO THE DELAYED NEUROTOXIC EFFECTS OF SOME ORGANOPHOSPHORUS ESTERSJournal of Neurochemistry, 1974